Hedge Fund - Octagon Capital Advisors
Taysha Gene Therapies Inc. (TSHA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $48,729,511 | 5.92% | 8,859,911 | $4.86 |
| 2 | 2025 - Q3 (2025-09-30) | $29,650,725 | 4.49% | 9,067,500 | $2.83 |
| 3 | 2025 - Q2 (2025-06-30) | $29,088,675 | 6.38% | 12,592,500 | $2.17 |
| 4 | 2025 - Q1 (2025-03-31) | $14,873,000 | 2.88% | 10,700,000 | $1.67 |
| 5 | 2024 - Q4 (2024-12-31) | $18,078,500 | 2.97% | 10,450,000 | $2.07 |
| 6 | 2024 - Q3 (2024-09-30) | $9,190,166 | 1.42% | 4,572,222 | $2.19 |
| 7 | 2024 - Q2 (2024-06-30) | $10,241,777 | 1.6% | 4,572,222 | $2.91 |
| 8 | 2024 - Q1 (2024-03-31) | $8,696,100 | 1.04% | 3,030,000 | $2.08 |
| 9 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $1.99 |
| 10 | 2023 - Q3 (2023-09-30) | $8,777,778 | 1.34% | 2,777,778 | $1.87 |
| 11 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $19.01 |
| 12 | 2021 - Q2 (2021-06-30) | $6,793,000 | 1.4% | 320,440 | $23.05 |
| 13 | 2021 - Q1 (2021-03-31) | $6,505,000 | 2.45% | 320,440 | $27.08 |
| 14 | 2020 - Q4 (2020-12-31) | $8,504,000 | 2.94% | 320,440 | $21.54 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center